
Processa Pharmaceuticals, Inc.
PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31
Reports and events: 260 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-11-0816:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-030942 |
| 2022-11-0411:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-030427 |
| 2022-09-0721:46 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-22-025171 |
| 2022-08-1210:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-022220 |
| 2022-08-1116:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022063 |
| 2022-08-0409:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-021259 |
| 2022-07-2516:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-020258 |
| 2022-07-1415:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-22-019301 |
| 2022-05-3108:00 ET | DEF 14A | Proxy statementPeriod 2022-05-31 | 0001493152-22-015428 |
| 2022-05-1617:20 ET | 8-K | 8.01 Other events | 0001493152-22-013963 |
| 2022-05-1216:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-013045 |
| 2022-05-1216:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013040 |
| 2022-05-0215:55 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001493152-22-011777 |
| 2022-03-3016:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-008156 |
| 2022-03-2416:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-007680 |
| 2022-03-1708:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-007101 |
| 2022-01-2608:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-002239 |
| 2022-01-0614:36 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-22-000543 |
| 2021-11-1206:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-027929 |
| 2021-11-0513:59 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-027320 |
| 2021-09-2014:51 ET | DEF 14A | Proxy statementPeriod 2021-09-20 | 0001493152-21-023145 |
| 2021-09-2008:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-023107 |
| 2021-08-2016:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-21-020817 |
| 2021-08-1306:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-019582 |
| 2021-08-1216:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-019495 |
| 2021-07-3018:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-018127 |
| 2021-07-1509:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-016906 |
| 2021-06-1711:35 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-014623 |
| 2021-06-1017:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-014058 |
| 2021-06-0913:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-013879 |
| 2021-05-2606:15 ET | 8-K | 1.02 Termination of a material agreement | 0001493152-21-012907 |
| 2021-05-2016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-012350 |
| 2021-05-1317:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-011353 |
| 2021-05-1316:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-011311 |
| 2021-04-2214:00 ET | DEF 14A | Proxy statementPeriod 2021-04-22 | 0001493152-21-009443 |
| 2021-04-0716:23 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001493152-21-008210 |
| 2021-03-2516:15 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-006807 |
| 2021-03-2516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-006793 |
| 2021-02-1810:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-004218 |
| 2021-01-1113:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-000718 |
| 2020-11-1216:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-20-021083 |
| 2020-11-0509:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-020540 |
| 2020-10-1310:08 ET | SC 13D | Ownership report, active investor | 0000897069-20-000396 |
| 2020-10-1309:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-019301 |
| 2020-10-0616:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-019018 |
| 2020-09-3016:06 ET | S-1/A | Registration statement, amended | 0001493152-20-018617 |
| 2020-09-1719:38 ET | S-1/A | Registration statement, amended | 0001493152-20-017927 |
| 2020-08-2709:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-016815 |
| 2020-08-2009:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-20-016387 |
| 2020-08-0515:32 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001493152-20-014712 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.